Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.
Christopher D Rosenbaum, Stephanie P Carreiro, Kavita M. Babu
Journal of Medical Toxicology March 1, 2012 DOI: 10.1007/s13181-011-0202-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | General (review of novel psychoactive substances) |
| Topics | Salvia divinorum Cannabis |
| Keywords | New psychoactive substances Nps Novel psychoactive substances Designer drugs Emerging drugs Recreational drugs Herbal blends Synthetic cathinones Legal ketamine K2 Bath salts Methoxetamine Kratom Public health risks Health concerns Drug safety Substance abuse risks Public safety Overdose Clinical management Healthcare provider education Medical toxicology Emergency medicine Drug exposure management Medical professionals Healthcare providers Drug treatment Patient care Drug pharmacology Drug effects Psychoactive effects Therapeutic potential Opioid-like effects Hallucinogenic effects Adverse effects Drug reactions Drug mechanisms Severe agitation Death |
| Citations | 356 |
| Key findings | Healthcare providers must become familiar with synthetic cannabinoids, synthetic cathinones, methoxetamine, and piperazine derivatives because these Internet-available drugs, often perceived as safe, can cause life-threatening adverse effects. |
Abstract
Despite their widespread Internet availability and use, many of the new drugs of abuse remain unfamiliar to health care providers. The herbal marijuana alternatives, like K2 or Spice, are a group of herbal blends that contain a mixture of plant matter in addition to chemical grade synthetic cannabinoids. The synthetic cathinones, commonly called "bath salts," have resulted in nationwide emergency department visits for severe agitation, sympathomimetic toxicity, and death. Kratom, a plant product derived from Mitragyna speciosa Korth, has opioid-like effects, and has been used for the treatment of chronic pain and amelioration of opioid-withdrawal symptoms. Salvia divinorum is a hallucinogen with unique pharmacology that has therapeutic potential but has been banned in many states due to concerns regarding its psychiatric effects. Methoxetamine has recently become available via the Internet and is marked as "legal ketamine." Moreover, the piperazine derivatives, a class of amphetamine-like compounds that includes BZP and TMFPP, are making a resurgence as "legal Ecstasy." These psychoactives are available via the Internet, frequently legal, and often perceived as safe by the public. Unfortunately, these drugs often have adverse effects, which range from minimal to life-threatening. Health care providers must be familiar with these important new classes of drugs. This paper discusses the background, pharmacology, clinical effects, detection, and management of synthetic cannabinoid, synthetic cathinone, methoxetamine, and piperazine exposures.
In the evidence
This study is part of the evidence base for 2 syntheses in the library. Here is how each one recorded it.
-
State of the evidence: Cannabis Opposes
Argues that synthetic cannabinoids in herbal marijuana alternatives and other novel psychoactive substances, often perceived as safe, can cause adverse effects ranging from minimal to life-threatening.
Synthesized
-
Salvia divinorum is described as a hallucinogen with unique pharmacology and therapeutic potential, but banned in many states due to concerns about psychiatric effects.
Synthesized
Comparable studies
Other narrative reviews on salvia divinorum, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Opioid receptors and legal highs:Salvia divinorumand Kratom | 2008 | Review | |
| Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. | 2003 | Review | |
| Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. | 1994 | Review | |
| Drug models of schizophrenia. General (review of drug models of schizophrenia) | 2015 | Review | |
| Psychopharmacology of the hallucinogenic sage Salvia divinorum. | 2005 | Review |
Citations in the library
Cited by 46
- 'Surfing the Silk Road': a study of users' experiences. International Journal of Drug Policy November 1, 2013
- Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines Journal of Neuroscience November 12, 2014
- New/emerging psychoactive substances and associated psychopathological consequences Psychological Medicine July 22, 2019
- 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. Journal of Medical Toxicology March 1, 2014
- “Not for Human Consumption”: A Review of Emerging Designer Drugs Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy April 8, 2014
and 41 more in the library
Cites 26
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European Journal of Pharmacology March 22, 2007
- Opioid receptors and legal highs:Salvia divinorumand Kratom Clinical Toxicology 2008
- "Legal highs" on the net-Evaluation of UK-based Websites, products and product information. Forensic Science International March 20, 2011
- Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology May 1, 2005
and 21 more in the library